Back to Search Start Over

Association of tricuspid regurgitation with clinical and echocardiographic outcomes after percutaneous mitral valve repair with the MitraClip System: 30-day and 12-month follow-up from the GRASP Registry.

Authors :
Yohei Ohno
Attizzani, Guilherme F.
Capodanno, Davide
Cannata, Stefano
Dipasqua, Fabio
Imme, Sebastiano
Barbanti, Marco
Ministeri, Margherita
Caggegi, Anna
Pistritto, Anna M.
Chiaranda, Marta
Ronsivalle, Giuseppe
Giaquinta, Sandra
Farruggio, Silvia
Mangiafico, Sarah
Scandura, Salvatore
Tamburino, Corrado
Capranzano, Piera
Grasso, Carmelo
Source :
European Heart Journal - Cardiovascular Imaging; Nov2014, p1246-1255, 10p
Publication Year :
2014

Abstract

Aim The aim of this study was to evaluate the association of baseline tricuspid regurgitation (TR) on the outcomes after percutaneous mitral valve repair (PMVR) with the MitraClip system. Methods and results Data from 146 consecutive patients with functional mitral regurgitation (MR) were obtained. Two different groups, dichotomized according to the degree of pre-procedural TR (moderate/severe, n = 47 and none/mild, n = 99), had their clinical and echocardiographic outcomes through 12-month compared. At 30-day, the primary safety endpoint was significantly higher in moderate/severe TR compared with none/mild TR (10.6 vs. 2.0%, P = 0.035). Marked reduction in MR grades observed post-procedure were maintained through 12 months. Although NYHA functional class significantly improved in both groups compared with baseline, it was impaired in moderate/severe TR compared with the none/mild TRgroup (NYHA > II at 30 day: 33.3 vs. 9.2%, P < 0.001; at 1 year: 38.5 vs. 12.3%, respectively, P = 0.006). Left ventricle reverse remodelling and ejection fraction improvement were revealed in both groups. The primary efficacy endpoint at 12-month determined by freedom from death, surgery for mitral valve dysfunction, or grade ≥3+ MR was comparable between groups, but combined death and re-hospitalization for heart failure rates were higher in the moderate/severe TR group. Multivariable Cox regression analysis demonstrated that baseline moderate/severe TR and chronic kidney disease were independent predictors of this combined endpoint. Conclusions Although PMVR with MitraClip led to improvement in MR, TR, and NYHA functional class in patients with baseline moderate/severe TR, the primary safety endpoint at 30-day was impaired, while moderate/severe TR independently predicted death and rehospitalization for heart failure at 12-month. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
20472404
Database :
Complementary Index
Journal :
European Heart Journal - Cardiovascular Imaging
Publication Type :
Academic Journal
Accession number :
110412547
Full Text :
https://doi.org/10.1093/ehjci/jeu114